Drug Type Small molecule drug |
Synonyms BMT-080676 |
Target |
Action agonists |
Mechanism mGluR2 agonists(Metabotropic glutamate receptor 2 agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Behavioural disorders | Preclinical | United States | - | |
| Behavioural disorders | Preclinical | United States | - | |
| Cognition Disorders | Discovery | United States | - | |
| Schizophrenia | Discovery | United States | - |





